<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//engeneic.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://engeneic.com/news/australian-story-for-the-holy-grail/</loc>
		<lastmod>2025-11-20T06:01:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/new-scientist-mini-cells-could-stop-side-effects-of-chemotherapy/</loc>
		<lastmod>2025-11-20T06:01:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/cosmos-magazine-killer-minicells-fight-drug-resistant-cancer/</loc>
		<lastmod>2025-11-20T06:01:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/new-york-times-new-cancer-treatment-shows-promise-in-testing/</loc>
		<lastmod>2025-11-20T06:02:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/ausbiotech-update-a-promise-to-a-dying-friend-turns-to-a-quest-for-a-cure/</loc>
		<lastmod>2025-11-20T06:02:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/australian-financial-review-unique-technique-brings-pets-back-from-deaths-door/</loc>
		<lastmod>2025-11-20T06:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/blue-mountains-gazette-hitting-cancer-for-six/</loc>
		<lastmod>2025-11-20T06:03:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/tenterfield-star-upclose-dr-jennifer-macdiarmid/</loc>
		<lastmod>2025-11-20T06:03:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/cancer-discovery-minicells-safely-deliver-targeted-drugs/</loc>
		<lastmod>2025-11-20T06:03:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/european-cancer-organisation-first-trial-in-humans-of-minicells-a-completely-new-way-of-delivering-anti-cancer-drugs/</loc>
		<lastmod>2025-11-20T06:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-unveils-clinical-development-strategy-for-edv-nanocell-technology/</loc>
		<lastmod>2025-11-20T06:04:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-receives-patent-from-the-uspto-for-edv-nanocell-technology/</loc>
		<lastmod>2025-11-20T06:04:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-named-a-recipient-of-the-cancer-institute-nsw-premiers-award-for-excellence-in-translational-cancer-research/</loc>
		<lastmod>2025-11-20T06:05:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-and-asbestos-diseases-research-institute-initiate-mesomir-1-phase-1-trial-in-patients-with-late-stage-mesothelioma/</loc>
		<lastmod>2025-11-20T06:05:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-completes-10-million-series-b-financing-led-by-u-s-institutional-investor/</loc>
		<lastmod>2025-11-20T06:05:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-to-present-at-bio-ceo-investor-conference-2015/</loc>
		<lastmod>2025-11-20T06:06:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/globe-newswire-foundation-for-sarcoidosis-research-announces-first-new-york-fundraiser-with-support-of-engeneic/</loc>
		<lastmod>2025-11-20T06:06:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-and-asbestos-diseases-research-institute-announce-encouraging-results-from-mesomir-1-phase-1-trial-in-late-stage-mesothelioma-patients/</loc>
		<lastmod>2025-11-20T06:07:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/sky-news-nanotech-trial-early-success/</loc>
		<lastmod>2025-11-20T06:08:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-recognized-as-one-of-the-most-innovative-organizations-in-australia-at-the-2015-thomson-reuters-australian-citation-innovation-awards/</loc>
		<lastmod>2025-11-20T06:08:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/indian-link-in-gene-ious/</loc>
		<lastmod>2025-11-20T06:08:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-initiates-phase-1-tailored-edv-clinical-study-in-solid-tumors/</loc>
		<lastmod>2025-11-20T06:09:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-ltd-to-initiate-u-s-phase-1-clinical-study-using-targeted-edv-nanocells-to-treat-advanced-glioma-patients/</loc>
		<lastmod>2025-11-20T06:09:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-ltd-to-present-at-the-14th-annual-bio-investor-forum/</loc>
		<lastmod>2025-11-20T06:09:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-ltd-to-present-at-the-stifel-2015-healthcare-conference/</loc>
		<lastmod>2025-11-20T06:09:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-limited-to-present-at-the-34th-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-11-20T06:10:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-ltd-strengthens-board-of-directors-to-support-u-s-expansion/</loc>
		<lastmod>2025-11-20T06:10:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-receives-science-meets-business-top-25-australian-rd-spin-off-companies-award/</loc>
		<lastmod>2025-11-20T06:11:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-ltd-to-present-at-bio-ceo-investor-conference-2016/</loc>
		<lastmod>2025-11-20T06:11:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-announces-publication-of-late-stage-canine-brain-cancer-study-results-in-plos-one/</loc>
		<lastmod>2025-11-20T06:11:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneics-joint-ceo-and-co-founder-jennifer-macdiarmid-ph-d-recognized-in-innovation-category-in-the-australian-financial-review-and-westpac-100-women-of-influence-awards-for-2016/</loc>
		<lastmod>2025-11-20T06:11:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-enters-into-research-collaboration-with-takeda-to-develop-edv-based-immunomodulatory-therapies-for-oncology/</loc>
		<lastmod>2025-11-20T06:12:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/cancer-breakthrough-sydney-scientists-record-near-complete-elimination-in-male-mesothelioma-patient-similar-results-in-dogs/</loc>
		<lastmod>2025-11-20T06:12:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-receives-fda-orphan-drug-designation-for-targeted-edv-nanocells-to-treat-glioblastoma-multiforme/</loc>
		<lastmod>2025-11-20T06:13:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-doses-first-patient-in-u-s-phase-1-clinical-study-of-targeted-edv-nanocells-in-recurrent-glioblastoma-multiforme/</loc>
		<lastmod>2025-11-20T06:14:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-announces-publication-in-the-lancet-oncology-of-first-clinical-study-employing-edv-nanocell-platform-to-enable-microrna-replacement-therapy/</loc>
		<lastmod>2025-11-20T06:14:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-announces-publication-of-preclinical-data-highlighting-potential-efficacy-of-egfr-targeted-edvtm-nanocells-to-treat-pediatric-neuroblastoma/</loc>
		<lastmod>2025-11-20T06:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-announces-first-patients-with-advanced-stage-pancreatic-cancer-dosed-in-phase-1-2a-clinical-study/</loc>
		<lastmod>2025-11-20T06:15:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-wins-australian-financial-review-innovation-awards-as-most-innovative-company-in-healthcare-in-australia-and-new-zealand/</loc>
		<lastmod>2025-11-20T06:15:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/winner-in-drug-delivery-technology-category-by-fierce-innovation-awards-life-sciences-edition-2019/</loc>
		<lastmod>2025-11-20T06:16:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-novel-oncology-focused-nanotechnology-featured-in-insightscare-the-10-most-innovative-healthcare-nanotech-companies-to-watch/</loc>
		<lastmod>2025-11-20T06:16:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/publication-in-prestigious-scientific-journal-cancer-cell-highlighting-the-ability-of-edv-nanocells-to-mount-dual-assault-on-cancer-cells/</loc>
		<lastmod>2025-11-20T06:17:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/abstract-accepted-to-the-annual-meeting-of-the-american-society-of-clinical-oncology-2020/</loc>
		<lastmod>2025-11-20T06:17:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-announces-board-appointment-dr-mark-levitt/</loc>
		<lastmod>2025-11-20T06:18:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/worldwide-business-kathy-ireland-interviews-jennifer-macdiarmid/</loc>
		<lastmod>2025-11-20T06:19:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-announces-board-appointment-professor-bryan-williams/</loc>
		<lastmod>2025-11-20T06:20:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-develops-world-first-nanocellular-anti-covid-19-vaccine-that-defeats-mutant-viruses-and-stimulates-a-broad-anti-viral-response/</loc>
		<lastmod>2025-11-20T06:20:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/channel-9-news-27th-july-2022/</loc>
		<lastmod>2025-11-20T06:20:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-has-won-the-2022-australian-financial-review-boss-prestigious-award-for-the-most-innovative-company-in-healthcare-australia-and-new-zealand/</loc>
		<lastmod>2025-11-20T06:21:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-publishes-the-covid-edv-vaccines-novel-mechanism-of-action-in-a-leading-immunology-journal/</loc>
		<lastmod>2025-11-20T06:21:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneics-promising-results-in-17-pancreatic-ductal-adenocarcinoma-patients-clinical-trial-published-in-clinical-cancer-research/</loc>
		<lastmod>2025-11-20T06:22:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-granted-fda-fast-track-designation-for-novel-armed-nanocell-drug-conjugate-pancreatic-cancer-therapeutic/</loc>
		<lastmod>2025-11-20T06:22:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-selects-global-cdmo-biocina-to-advance-their-groundbreaking-cancer-treatment/</loc>
		<lastmod>2025-11-20T06:23:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-launches-groundbreaking-new-australian-trial-for-innovative-cancer-therapy-with-international-trial-site-in-singapore-to-follow/</loc>
		<lastmod>2025-11-20T06:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://engeneic.com/news/engineering-precision-therapies-for-the-new-era-of-cancer-care/</loc>
		<lastmod>2026-07-29T23:40:27+00:00</lastmod>
		<image:image>
			<image:loc>https://engeneic.com/wp-content/uploads/2026/06/Fearless-scaled.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneic-honored-with-2026-breakthrough-in-glioblastoma-biotech-award-at-northwell-foundation-lenox-hill-neurosurgery-brain-cancer-gala-in-new-york/</loc>
		<lastmod>2026-07-29T23:40:55+00:00</lastmod>
		<image:image>
			<image:loc>https://engeneic.com/wp-content/uploads/2026/07/engeneic-glioblastoma-award-gala-2026.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://engeneic.com/news/engeneics-advanced-metastatic-pancreatic-ductal-adenocarcinoma-patient-makes-full-recovery/</loc>
		<lastmod>2026-07-29T23:52:40+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->